Literature DB >> 24795524

Development and Implementation of Health and Wellness CBT for Individuals with Depression and HIV.

B Kennard1, L Brown2, L Hawkins3, A Risi4, J Radcliffe3, G Emslie1, T Mayes1, J King1, A Foxwell1, J Buyukdura1, J Bethel5, S Naar-King6, J Xu5, S Lee7, P Garvie8, C London8, M Tanney3, S Thornton5.   

Abstract

Rates of depression are reported to be between 22-33% in adults with HIV, which is double that of the general population. Depression negatively affects treatment adherence and health outcomes of those with medical illnesses. Further, it has been shown in adults that reducing depression may improve both adherence and health outcomes. To address the issues of depression and non-adherence, Health and Wellness (H&W) Cognitive Behavioral Therapy (CBT) and medication management (MM) treatment strategies have been developed specifically for youth living with both HIV and depression. H&W CBT is based on other studies with uninfected youth and upon research on adults with HIV. H&W CBT uses problem-solving, motivational interviewing, and cognitive-behavioral strategies to decrease adherence obstacles and increase wellness. The intervention is delivered in 14 planned sessions over a 6-month period, with three different stages of CBT. This paper summarizes the feasibility and acceptability data from an open depression trial with 8 participants, 16-24 years of age, diagnosed with HIV and with a Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnosis of depression, conducted at two treatment sites in the Adolescent Trials Network (ATN). Both therapists and subjects completed a Session Evaluation Form (SEF) after each session, and results were strongly favorable. Results from The Quick Inventory of Depressive Symptomatology-Clinician (QIDS-C) also showed noteworthy improvement in depression severity. A clinical case vignette illustrates treatment response. Further research will examine the use of H&W CBT in a larger trial of youth diagnosed with both HIV and depression.

Entities:  

Keywords:  Adherence; Cognitive Behavioral Therapy (CBT); Health; Human Immunodeficiency Virus (HIV); Major Depressive Disorder (MDD)

Year:  2014        PMID: 24795524      PMCID: PMC4002170          DOI: 10.1016/j.cbpra.2013.07.003

Source DB:  PubMed          Journal:  Cogn Behav Pract        ISSN: 1077-7229


  23 in total

1.  Psychosocial factors and medication adherence in HIV-positive youth.

Authors:  Sylvie Naar-King; Thomas Templin; Kathryn Wright; Maureen Frey; Jeffrey T Parsons; Phebe Lam
Journal:  AIDS Patient Care STDS       Date:  2006-01       Impact factor: 5.078

Review 2.  Psychological well-being: meaning, measurement, and implications for psychotherapy research.

Authors:  C D Ryff; B Singer
Journal:  Psychother Psychosom       Date:  1996       Impact factor: 17.659

3.  Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.

Authors:  Steven A Safren; Conall M O'Cleirigh; Jacqueline R Bullis; Michael W Otto; Michael D Stein; Mark H Pollack
Journal:  J Consult Clin Psychol       Date:  2012-04-30

4.  A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.

Authors:  Steven A Safren; Conall O'Cleirigh; Judy Y Tan; Sudha R Raminani; Laura C Reilly; Michael W Otto; Kenneth H Mayer
Journal:  Health Psychol       Date:  2009-01       Impact factor: 4.267

5.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

Review 6.  Interpersonal psychotherapy for depressed adolescents (IPT-A).

Authors:  Anat Brunstein-Klomek; Gil Zalsman; Laura Mufson
Journal:  Isr J Psychiatry Relat Sci       Date:  2007       Impact factor: 0.481

7.  The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial.

Authors:  David A Brent; Laurence L Greenhill; Scott Compton; Graham Emslie; Karen Wells; John T Walkup; Benedetto Vitiello; Oscar Bukstein; Barbara Stanley; Kelly Posner; Betsy D Kennard; Mary F Cwik; Ann Wagner; Barbara Coffey; John S March; Mark Riddle; Tina Goldstein; John Curry; Shannon Barnett; Lisa Capasso; Jamie Zelazny; Jennifer Hughes; Sa Shen; S Sonia Gugga; J Blake Turner
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-10       Impact factor: 8.829

8.  Psychopharmacologic treatment of patients with HIV/AIDS.

Authors:  Stephen J Ferrando
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

Review 9.  Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management.

Authors:  Amy H Cheung; Rachel A Zuckerbrot; Peter S Jensen; Kareem Ghalib; Danielle Laraque; Ruth E K Stein
Journal:  Pediatrics       Date:  2007-11       Impact factor: 7.124

10.  Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.

Authors:  Boris Birmaher; David Brent; William Bernet; Oscar Bukstein; Heather Walter; R Scott Benson; Allan Chrisman; Tiffany Farchione; Laurence Greenhill; John Hamilton; Helene Keable; Joan Kinlan; Ulrich Schoettle; Saundra Stock; Kristin Kroeger Ptakowski; Jennifer Medicus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-11       Impact factor: 8.829

View more
  16 in total

1.  Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.

Authors:  Gayatri Mirani; Paige L Williams; Miriam Chernoff; Mark J Abzug; Myron J Levin; George R Seage; James M Oleske; Murli U Purswani; Rohan Hazra; Shirley Traite; Bonnie Zimmer; Russell B Van Dyke
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

2.  A Systematic Review and Meta-Analysis of Combination Behavioral Interventions Co-Targeting Psychosocial Syndemics and HIV-Related Health Behaviors for Sexual Minority Men.

Authors:  David W Pantalone; Kimberly M Nelson; Abigail W Batchelder; Christopher Chiu; Hamish A Gunn; Keith J Horvath
Journal:  J Sex Res       Date:  2020-02-20

3.  Predictors and Profiles of Antiretroviral Therapy Adherence Among African American Adolescents and Young Adult Males Living with HIV.

Authors:  Israel Moses Gross; Sybil Hosek; Maryse Heather Richards; M Isabel Fernandez
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

4.  Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States.

Authors:  Larry K Brown; Miriam Chernoff; Betsy D Kennard; Graham J Emslie; Kathryn Lypen; Sarah Buisson; Adriana Weinberg; Laura B Whiteley; Shirley Traite; Chelsea Krotje; Lauren Harriff; Ellen Townley; Amber Bunch; Murli Purswani; Ray Shaw; Stephen A Spector; Allison Agwu; David E Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2021-12-15       Impact factor: 3.771

5.  Narratives of Change From Gay and Bisexual Men Living With HIV in an Emotional Well-Being Intervention.

Authors:  Sophia M Bartels; Karla Guzmán Guevara; Yolanda Pajarito Rompich; Clare Barrington
Journal:  AIDS Educ Prev       Date:  2022-02

6.  Understanding HIV-Related Pill Aversion as a Distinct Barrier to Medication Adherence.

Authors:  Robin M Dorman; Sarah H Sutton; Lynn M Yee
Journal:  Behav Med       Date:  2019-01-03       Impact factor: 3.104

7.  Subtypes of depressive symptoms and inflammatory biomarkers: An exploratory study on a sample of HIV-positive patients.

Authors:  A Norcini Pala; P Steca; R Bagrodia; L Helpman; V Colangeli; P Viale; M L Wainberg
Journal:  Brain Behav Immun       Date:  2016-02-13       Impact factor: 7.217

8.  Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.

Authors:  Larry K Brown; Betsy D Kennard; Graham J Emslie; Taryn L Mayes; Laura B Whiteley; James Bethel; Jiahong Xu; Sarah Thornton; Mary R Tanney; Linda A Hawkins; Patricia A Garvie; Geetha A Subramaniam; Carol J Worrell; Laura W Stoff
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

9.  PrEP Implementation Science: State-of-the-Art and Research Agenda.

Authors:  Carlos F Cáceres; Kenneth H Mayer; Rachel Baggaley; Kevin R O'Reilly
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

Review 10.  Adolescents and young adults with early acquired HIV infection in the united states: unique challenges in treatment and secondary prevention.

Authors:  Hasiya Yusuf; Allison Agwu
Journal:  Expert Rev Anti Infect Ther       Date:  2020-11-01       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.